2022 American Transplant Congress
June 4-8, 2022 in Boston, MA
The ATC program is built in the Eastern Time Zone.
- Administrative (0)
- Basic & Clinical Science (0)
- Basic Science (0)
- Basic Clinical Science (0)
- Basic Science (0)
- 02 - Acute Rejection (25)
- 03 - Antigen Presentation / Allorecognition / Dendritic Cells (14)
- 04 - B-cell / Antibody /Autoimmunity (32)
- 05 - Translational Cellular Therapies: Islet and Stem Cell Transplantation (13)
- 06 - Tissue Engineering and Regenerative Medicine (17)
- 07 - Vascular, Lymphatic, Stromal and Parenchymal Cell Biology (16)
- 08 - Innate Immunity; Chemokines, Cytokines, Complement (25)
- 09 - Signaling and Co-Stimulation (9)
- 10 - Treg/Other Regulatory Cell/Tolerance (44)
- 11 - Histocompatibility and Immunogenetics (14)
- 12 - Immunosuppression & Tolerance: Preclinical & Translational Studies (35)
- 13 - Xenotransplantation (22)
- 14 - Ischemia Reperfusion (43)
- 15 - Machine Perfusion and Organ Rehabililtation - Basic (26)
- 16 - Biomarkers: -omics and Systems Biology (27)
- Clinical Science (0)
- Ethics (0)
- Heart (0)
- Infection Disease (0)
- Kidney (0)
- 31 - Kidney Deceased Donor Allocation (29)
- 32 - Kidney Deceased Donor Selection (56)
- 33 - Kidney Psychosocial (22)
- 34 - Kidney: Acute Cellular Rejection (21)
- 35 - Kidney: Cardiovascular and Metabolic Complications (59)
- 36 - Kidney Immunosuppression: Desensitization (14)
- 37 - Kidney Immunosuppression: Induction Therapy (18)
- 38 - Kidney Immunosuppression: Novel Regimens and Drug Minimization (43)
- 39 - Kidney Living Donor: Long Term Outcomes (22)
- 40 - Kidney Living Donor: Other (25)
- 41 - Kidney Technical (24)
- 42 - Kidney Living Donor: Selection (12)
- 43 - Kidney: Pediatrics (45)
- 44 - Kidney Acute Antibody Mediated Rejection (18)
- 45 - Kidney Chronic Antibody Mediated Rejection (15)
- 46 - Kidney Complications: Non-Immune Mediated Late Graft Failure (17)
- 47 - Kidney Complications: Immune Mediated Late Graft Failure (16)
- 48 - Kidney Paired Exchange (7)
- 49 - Recurrent Kidney Disease & Genetics (21)
- 50 - Health Equity and Access (53)
- Liver (0)
- 51 - Liver: Retransplantation and Other Complications (22)
- 52 - Liver: Kidney Issues in Liver Transplantation (19)
- 53 - Liver: Cirrhosis - Portal Hypertension and Other Complications (16)
- 54 - Liver: Immunosuppression and Rejection (7)
- 55 - Liver: Recipient Selection (31)
- 56 - Liver: Hepatocellular Carcinoma and Other Malignancies (26)
- 57 - Liver: Surgery Innovative Techniques* (12)
- 58 - Liver: Living Donor Liver Transplant and Partial Grafts (20)
- 59 - Liver: Expanding the Donor Pool* (Liver: MELD Allocation / Donor Issues) (27)
- 60 - Liver: MELD Allocation* (15)
- 61 - Liver: Pediatrics (29)
- 62 - Liver: Large Data and Artificial Intelligence (8)
- Lung (0)
- Organ Inclusive (0)
- 67 - Non-PTLD/Malignancies (9)
- 68 - Deceased Donor Management and Intervention Research (18)
- 69 - Non-Organ Specific:Organ Preservation/Ischemia Reperfusion Injury (15)
- 70 - Non-Organ Specific: Disparities to Outcome and Access to Healthcare (35)
- 71 - Surgical Issues (Open, Minimally Invasive):All Organs (7)
- 72 - Machine Learning, Artificial Intelligence and Social Media in Transplantation (24)
- Pancreas (0)
- Pharmacy (0)
- Public Policy (0)
- Small Bowel (0)